Comparison between Jiwanram Sheoduttrai IPO and Saroja Pharma IPO.
Jiwanram Sheoduttrai IPO is a SME Fixed Price IPO proposed to list at NSE SME while Saroja Pharma IPO is a SME Fixed Price proposed to list at NSE SME.
| Jiwanram Sheoduttrai IPO | Saroja Pharma IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Fixed Price |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Affinity Global Capital Market Pvt.Ltd. | Swastika Investmart Ltd. |
| Registrar | Cameo Corporate Services Ltd. | Kfin Technologies Ltd. |
| Market Maker | Giriraj Stock Broking Pvt.Ltd. | Swastika Investmart Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Jiwanram Sheoduttrai IPO is up to ₹16.22 Cr whereas the issue size of the Saroja Pharma IPO is up to ₹8.66 Cr. The final issue price of Jiwanram Sheoduttrai IPO is ₹23.00 per share and of Saroja Pharma IPO is ₹84.00 per share.
| Jiwanram Sheoduttrai IPO | Saroja Pharma IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹23.00 per share | ₹84.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 6000 shares | 1600 shares |
| Fresh Issue Size | 70,50,000 shares | 10,30,400 shares |
| Fresh Issue Size (Amount) | up to ₹16.22 Cr | up to ₹8.66 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 70,50,000 shares | 10,30,400 shares |
| Issue Size Total (Amount) | up to ₹16.22 Cr | up to ₹8.66 Cr |
Jiwanram Sheoduttrai IPO opens on Sep 08, 2023, while Saroja Pharma IPO opens on Aug 31, 2023. The closing date of Jiwanram Sheoduttrai IPO and Saroja Pharma IPO is Sep 12, 2023, and Sep 05, 2023, respectively.
| Jiwanram Sheoduttrai IPO | Saroja Pharma IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Sep 08, 2023 | Aug 31, 2023 |
| Issue Close | Sep 12, 2023 | Sep 05, 2023 |
| Basis Of Allotment (Tentative) | Sep 15, 2023 | Sep 08, 2023 |
| Initiation of Refunds (Tentative) | Sep 18, 2023 | Sep 11, 2023 |
| Credit of Share (Tentative) | Sep 20, 2023 | Sep 12, 2023 |
| Listing date (Tentative) | Sep 18, 2023 | Sep 13, 2023 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Jiwanram Sheoduttrai IPO P/E ratio is 9.91, as compared to Saroja Pharma IPO P/E ratio of 23.25.
| Jiwanram Sheoduttrai IPO | Saroja Pharma IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated Standalone)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 100 | 100.00 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 70.01 | 73.02 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 9.91 | 23.25 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹56.92 Cr. | ₹33.77 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 8.38% | 15 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 7.29% | 25 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 1.10 | 2.00 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹2.32 | ₹3.61 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 8.38% | 20.85 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Jiwanram Sheoduttrai IPO Retail Individual Investors (RII) are offered 35,28,000 shares while in Saroja Pharma IPO retail investors are offered 35,28,000 shares. Qualified Institutional Buyers (QIB) are offered in Jiwanram Sheoduttrai IPO and in Saroja Pharma IPO.
| Jiwanram Sheoduttrai IPO | Saroja Pharma IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | 3,72,000 shares | 54,400 shares |
| QIB | ||
| NII | 35,22,000 shares | 5,15,200 shares |
| RII | 35,28,000 shares | 5,15,200 shares |
| Employee | ||
| Others | ||
| Total | 70,50,000 shares | 10,30,400 shares |
Jiwanram Sheoduttrai IPO subscribed 112.96x in total, whereas Saroja Pharma IPO subscribed 8.88x.
| Jiwanram Sheoduttrai IPO | Saroja Pharma IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 69.75x | 2.90x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 151.47x | 14.83x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 112.96x | 8.88x |
